Dymista azelastine/fluticasone regulatory update

Meda said FDA extended the PDUFA date by 3 months for an NDA for Dymista azelastine/fluticasone to treat seasonal allergic rhinitis in patients ages >=12 years to early May 2012. According to the comp...